Navigation Links
Legal and Ethical Violations Risks Seen Rising, But Not Resources to Control the Risk

MINNEAPOLIS, Jan. 6 /PRNewswire-USNewswire/ -- A survey recently conducted by the Society of Corporate Compliance and Ethics (SCCE) and the Health Care Compliance Association (HCCA) reveals that the declining economy may be increasing the risk of legal and ethics violations in business. In addition, this increased risk is occurring at a time when budgets to manage those risks are expected to at best hold steady, if not decline.

The survey, based on an online questionnaire completed by more than 600 compliance and business ethics professionals, showed that 85% feel that the current economy greatly or somewhat increases the risk of compliance and ethics failures. So pervasive is the perception that only 1% took the contrarian view and felt that the legal and ethics risks might decline in this period, and not one respondent felt that the risk of compliance and ethics failures had greatly decreased.

The fear of increased risk was greatest among those outside of the health care industry, where 48% felt the risks were increasing greatly, compared to 30% for health care compliance professionals. According to Roy Snell, the CEO of both SCCE and HCCA, "The difference is to be expected since health care tends to be less impacted by changes in the economy than business as a whole."

The Society of Corporate Compliance and Ethics and Health Care Compliance Association are non-profit membership organizations serving ethics and compliance professionals across industry and in approximately 25 countries.

Warning of Future Corporate Scandals

In what may be a warning sign of future corporate scandals, despite the increase in perceived risk, survey respondents were far more likely to believe that their budgets and staffing would decline rather than increase. Forty-nine percent felt their budget would stay about the same, and 69% thought the same of staffing. But 36% felt their budgets were likely to decline and 21% are anticipating reductions in staffing. This compares to just 16% who expect an increase in budget and 11% who anticipate a staffing increase.

In terms of their own job security, 22% felt that their job was somewhat or much more at risk than the jobs of their peers in their organizations, and 44% were "not at all" concerned about losing their job as a result of the current economy.

"There's good and bad news here," observed Snell. "We're finding that companies are increasingly seeing compliance and ethics as an integral part of their business and not a luxury to be discarded during an economic downturn. But, at the same time, we're seeing stagnant budgets or potential declines in resources at a time of increased risk for failures. That's creating a gap that could prove to be a dangerous chasm for business to cross.

"A very real concern for compliance professionals is that some may interpret or blame future failures on poor performance of compliance and ethics programs, rather than on level-funding or decreased funding at a time of need. There needs to be a real understanding of the risks created in these uncertain times and what it will take to meet those risks," added Snell.

The complete survey can be accessed at or

Contact SCCE and HCCA

The SCCE and the HCCA are located at 6500 Barrie Road, Suite 250, Minneapolis, MN. Visit the SCCE Web site at or call toll-free 888 277 4977 or +1 952 933 4977. Visit the HCCA Web site at or call toll-free 888 580 8373 or +1 952 988 0141.

SOURCE Society of Corporate Compliance and Ethics
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Silverman, McDonald & Friedman Opens New Office in New Castle to Serve Legal Needs of Delaware Families
2. The Doctors Company Launches Southeast Legal Summit to Provide Industry's Best Claims Defense for Physicians
3. LegalView Updates its Baxter Heparin Information Portal with Conflicting News Reports on the Possible Dangers
4. The Doctors Company Launches Southeast Legal Summit to Provide Industry's Best Claims Defense for Physicians
5. LegalView Reports That Skin Cancer Drug May Offer Treatment to Mesothelioma Patients
6. United American Healthcare Corporation Issues Statement on Legal Motion Regarding Stock Repurchase Program
7. LegalView Updates Brain Injury Site with Information on TBI Disabled Soldier's Family
8. Doctors questions about end-of-life legalities may result in patient pain
9. LegalView Reports Record Numbers of Drug Reactions in U.S., Partially Caused by Heparin
10. LegalView Informs Chantix Patients of Risk of Seizures Leading to Traffic Accidents
11. LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 02, 2015 , ... Ruth Pearson ... brutal lupus flare-up. Unable to walk without assistance and quickly losing hope of recovering ... then a miracle happened. , Pearson was attending a women’s retreat when she experienced ...
(Date:12/1/2015)... ... December 01, 2015 , ... The Multiple System Atrophy Coalition ... funds for Multiple System Atrophy (MSA) research, timed today to coincide with Giving Tuesday ... from patients including their ability to work and be productive, to do simple daily ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Royal River Natural ... new study that found post-menopausal women who took the nutritional supplement creatine, along with ... who trained but did not take creatine. , The report is part of the ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... leadless pacemakers in the U.S. and is the only hospital in the region ... largest clinical data presentation of transcatheter pacing patients were revealed recently at a ...
(Date:12/1/2015)... ... 01, 2015 , ... December 1, 2015 -- InstantLabs is ... growing product line of food safety and seafood fraud prevention tools. , The ... allow InstantLabs to offer fast, reliable species identification for the four most popular ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... Russia has always been a ... new drugs registered in Europe in 2015 were ... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... Russia has always been a country of choice for global ...
(Date:12/1/2015)... , Dec. 1, 2015 CytRx Corporation (NASDAQ: ... specializing in oncology, today announced that it has reached ... pivotal global Phase 3 clinical trial of aldoxorubicin in ... originally estimated to be completed in Q1 2016. The Phase ... under a Special Protocol Assessment from the FDA at ...
(Date:12/1/2015)... 1, 2015  The migration to value-based care ... care plans that help patients stay healthy and ... be digitally enabled, incorporate care guidelines and be ... They will also allow all stakeholders to collaborate ... is optimal. That is the vision, however, research ...
Breaking Medicine Technology: